Streamline Health Solutions
STRM
STRM was delisted on the 11th of August, 2025.
31 hedge funds and large institutions have $18.7M invested in Streamline Health Solutions in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
3% more funds holding
Funds holding: 30 → 31 (+1)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
0.69% less ownership
Funds ownership: 2.32% → 1.64% (-0.69%)
24% less capital invested
Capital invested by funds: $24.7M → $18.7M (-$5.96M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$510K |
| 2 |
NHC
Nicholas Hoffman & Company
Atlanta,
Georgia
|
+$143K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$42.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15K |
| 5 |
BC
Bartlett & Co
Cincinnati,
Ohio
|
+$14.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$7.35M |
| 2 |
RAM
Roumell Asset Management
Chevy Chase,
Maryland
|
-$625K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$38.6K |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$20K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$15.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $2K | -$15.3K | -712 | -91% |
|
27
Osaic Holdings
Scottsdale,
Arizona
| $2K | – | – | – |
|
28
Morgan Stanley
New York
| $1K | +$1.33K | +62 | +886% |
|
|
TA
29
Tamarack Advisers
Carlsbad,
California
| – | -$7.35M | -328,725 | Closed |
|
|
RAM
30
Roumell Asset Management
Chevy Chase,
Maryland
| – | -$625K | -28,333 | Closed |
|
|
TDC
31
Thompson Davis & Co
Richmond,
Virginia
| – | -$20K | -908 | Closed |
|
STRM Hedge Fund Activity: Q1 2022 in Review
31 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Streamline Health Solutions (STRM) for Q1 2022, worth a combined $18.7M — down 24% from $24.7M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new STRM positions and 3 closed out — a net gain of 1 holder — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $510K. The largest seller was Tamarack Advisers, exiting entirely with an estimated $7.35M sold.
- 31 institutional investors held Streamline Health Solutions (STRM) as of Q1 2022, up from 30 in Q4 2021.
- Funds reported $18.7M of Streamline Health Solutions stock for Q1 2022, down 24% quarter-over-quarter.
- 4 funds opened new Streamline Health Solutions positions in Q1 2022 and 3 closed out, a net change of +1 holder.
- The largest Streamline Health Solutions buyer in Q1 2022 was Vanguard Group, an estimated $510K added.
- The largest Streamline Health Solutions seller in Q1 2022 was Tamarack Advisers, an estimated $7.35M sold.
Based on aggregated 13F filings for Q1 2022.